Adial Pharmaceuticals, Inc. (ADIL) DCF Valuation

Adial Pharmaceuticals, Inc. (ADIL) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Adial Pharmaceuticals, Inc. (ADIL) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment strategies with the Adial Pharmaceuticals, Inc. (ADIL) DCF Calculator! Utilize accurate financial data, adjust growth predictions and expenses, and instantly observe how these modifications affect the intrinsic value of Adial Pharmaceuticals, Inc. (ADIL).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -8.1 -10.9 -19.5 -13.3 -7.0 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 .1 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -8.1 -10.9 -19.5 -13.3 -7.0 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 6.8 4.4 6.1 4.0 2.8 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .2 .6 .3 .3 .1 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 -.1 .0 6.8 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -8.1 -10.9 -19.4 -13.3 -7.0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -8.0 -10.4 -19.8 -13.3 -.3 -.1 .0 .0 .0 .0
WACC, % 10.57 10.57 10.57 10.57 10.57 10.57 10.57 10.57 10.57 10.57
PV UFCF
SUM PV UFCF -.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -3
Equity Value 3
Diluted Shares Outstanding, MM 1
Equity Value Per Share 1.90

What You Will Get

  • Real Adial Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Adial Pharmaceuticals, Inc. (ADIL).
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates specific to Adial Pharmaceuticals.
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Adial’s fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections related to Adial Pharmaceuticals, Inc. (ADIL).
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility for Adial Pharmaceuticals.

Key Features

  • Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for Adial Pharmaceuticals, Inc. (ADIL).
  • Customizable WACC Calculator: Features a pre-built Weighted Average Cost of Capital sheet with adjustable inputs specific to the pharmaceutical sector.
  • Flexible Forecast Assumptions: Easily modify growth projections, capital expenditures, and discount rates to suit your analysis.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to Adial Pharmaceuticals, Inc. (ADIL).
  • Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review Adial Pharmaceuticals, Inc.'s pre-filled financial data and forecasts.
  3. Step 3: Modify critical inputs like revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Watch the DCF model update instantly as you tweak assumptions.
  5. Step 5: Analyze the outputs and use the results for investment decisions regarding Adial Pharmaceuticals, Inc. (ADIL).

Why Choose This Calculator for Adial Pharmaceuticals, Inc. (ADIL)?

  • Comprehensive Tool: Features DCF, WACC, and financial ratio analyses tailored for pharmaceutical investments.
  • Customizable Inputs: Modify yellow-highlighted fields to explore different investment scenarios.
  • Detailed Insights: Automatically computes Adial’s intrinsic value and Net Present Value.
  • Preloaded Data: Historical and projected data provide reliable foundations for analysis.
  • Professional Quality: Perfect for financial analysts, investors, and consultants in the biotech sector.

Who Should Use This Product?

  • Investors: Evaluate Adial Pharmaceuticals, Inc. (ADIL) to make informed decisions on buying or selling shares.
  • CFOs and Financial Analysts: Optimize valuation methodologies and assess financial projections for Adial.
  • Startup Founders: Gain insights into how companies like Adial Pharmaceuticals are valued in the market.
  • Consultants: Provide comprehensive valuation analyses and reports for clients interested in Adial.
  • Students and Educators: Utilize real-time data from Adial to practice and teach valuation skills effectively.

What the Template Contains

  • Preloaded ADIL Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.